Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q1 2026 Earnings Presentation
15 slides from Detection Technology Oy's earnings presentation, Apr 23, 2026
Slide 1: Q1 Business review January–March 2026
Q1 Business review January–March 2026 President and CEO Hannu Martola | 23 April 2026
Slide 2: Q1 2026 net sales and EBITA
Q1 2026 25.3 13.5 2.4 9.3 net sales, €m net sales change-% EBITA, €m EBITA-% (22.2) (-2.0) (1.4) (6.3) 2 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 3: Q1: Growth in all business applications and markets
Q1: Growth in all business applications and markets Total net sales grew at a double-digit rate Industrial sales +24% • Sales of line scan solutions grew strongly across all regions, primarily driven by the food industry • The growth in TFT sales continued Medical sales +16% • Growth driven by CT ap
Slide 4: Net sales by quarter
Net sales by quarter (EUR 1,000) 35,000 30,000 13.5 25,000 20,000 15,000 (YOY change-%) 10,000 5,000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2023 2024 2025 2026 4 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 5: Operating margin (EBITA) excluding NRI
Operating margin (EBITA) excluding NRI (EUR 1,000) 6,000 25% 5,000 20% 4,000 16.3% 15.3% 15% 14.8% 3,000 12.7% 12.4% 11.4% 10.0% 10% 9.0% 9.3% 2,000 6.3% 7.0% 6.5% 5.4% 5% 1,000 0 0% Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425 Q126 EBITA excluding NRI (EUR 1,000) EBITA-% excluding NR
Slide 6: Q1 2026 sales split by regional business units
Q1 2026 sales split by regional business units NET SALES €m YOY CHANGE-% 4.6% 25.9% AMERICAS 1.2 32.7 TOTAL NET SALES 25.3 €m APAC 17.6 10.1 69.6% EMEIA 6.5 20.7 6 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 7: Q1 2026 sales split by main applications
Q1 2026 sales split by main applications NET SALES €m YOY CHANGE-% 32.0% 18.4% INDUSTRIAL 4.6 23.5 TOTAL NET SALES 25.3 €m MEDICAL 12.6 15.9 49.7% SECURITY 8.1 5.3 7 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 8: Key figures
Key figures Q1 2026 Q1 2025 FY 2025 Net sales, EUR 1,000 25,264 22,249 101,023 Change in net sales, % 13.5% -2.0% -6.0% EBITA, EUR 1,000 2,351 1,399 9,255 EBITA, % 9.3% 6.3% 9.2% R&D costs, EUR 1,000 2,773 2,634 11,266 R&D costs, % of net sales 11.0% 11.8% 11.2% Cash flow from operating activities,
Slide 9: Strategic levers
Strategic levers BASE TFT ADDED VALUE NEW TECH Continue to do what we Drive TFT flat panel Commercialize more value- Seek new opportunities do, better growth, across regions and added integrated HW-SW beyond current scope markets solutions to a broader (Photon counting & SW) customer base Being the
Slide 10: AIDA commercialized and the first deliveries completed
AIDA commercialized and the first deliveries completed ADDED VALUE • Scalable detector platforms with integrated software • Algorithms & AI enhance image quality and enable low-dose, high-quality 3D imaging • Integrated architecture enables to develop new data-generating solutions for further added
Slide 11: X-ACE HS
X-ACE HS Launched AIDA BASE compatible, off- the-shelf CT detector family for high-speed and low-dose medical imaging 11 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 12: Sales expectation Q2 and Q3 2026
Sales expectation Q2 and Q3 2026 Industrial Medical Security to decline to grow to grow in Q2 in Q2 in Q2 Q2 sales are expected to grow in all regions: APAC, EMEIA, and the Americas YOY total net sales to grow in Q2 and Q3 2026 12 23.4.2026 Detection Technology | Business review January—March 2026 p
Slide 13: Business outlook
Business outlook Detection Technology expects total net sales to grow year-on-year in Q2 and Q3 2026. The geopolitical situation, new U.S. import tariffs, and price competition especially in China create uncertainty. 13 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 14: Financial targets
FINANCIAL TARGETS MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend sales growth margin (EBITA) >10% 15% 30-60% 14 23.4.2026 Detection Technology | Business review January—March 2026 presentation
Slide 15: www.deetee.com
Detection Technology